ATE489481T1 - Verfahren zur risikobeurteilung, überlebensvorhersage und behandlung von herzversagen und anderen leiden auf der grundlage von polymorphismen adrenerger rezeptoren - Google Patents

Verfahren zur risikobeurteilung, überlebensvorhersage und behandlung von herzversagen und anderen leiden auf der grundlage von polymorphismen adrenerger rezeptoren

Info

Publication number
ATE489481T1
ATE489481T1 AT04816181T AT04816181T ATE489481T1 AT E489481 T1 ATE489481 T1 AT E489481T1 AT 04816181 T AT04816181 T AT 04816181T AT 04816181 T AT04816181 T AT 04816181T AT E489481 T1 ATE489481 T1 AT E489481T1
Authority
AT
Austria
Prior art keywords
sub
polymorphisms
beta
adrenergic receptor
treatment
Prior art date
Application number
AT04816181T
Other languages
English (en)
Inventor
Stephen Liggett
Lynne Wagoner
Original Assignee
Univ Cincinnati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cincinnati filed Critical Univ Cincinnati
Application granted granted Critical
Publication of ATE489481T1 publication Critical patent/ATE489481T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
AT04816181T 2003-09-12 2004-09-13 Verfahren zur risikobeurteilung, überlebensvorhersage und behandlung von herzversagen und anderen leiden auf der grundlage von polymorphismen adrenerger rezeptoren ATE489481T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50283703P 2003-09-12 2003-09-12
PCT/US2004/029838 WO2005025409A2 (en) 2003-09-12 2004-09-13 Methods for risk assessment, survival prediction and treatment of heart failure and other conditions based on adrenergic receptor polymorphisms

Publications (1)

Publication Number Publication Date
ATE489481T1 true ATE489481T1 (de) 2010-12-15

Family

ID=34312422

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04816181T ATE489481T1 (de) 2003-09-12 2004-09-13 Verfahren zur risikobeurteilung, überlebensvorhersage und behandlung von herzversagen und anderen leiden auf der grundlage von polymorphismen adrenerger rezeptoren

Country Status (7)

Country Link
US (1) US7449292B2 (de)
EP (1) EP1670954B1 (de)
AT (1) ATE489481T1 (de)
AU (1) AU2004272102A1 (de)
CA (1) CA2538222A1 (de)
DE (1) DE602004030271D1 (de)
WO (1) WO2005025409A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1576352B1 (de) * 2002-09-09 2010-04-14 University Of Cincinnati Verfahren zur herzerkrankungsbewertung in einer einzelperson
US20090228995A1 (en) * 2004-06-29 2009-09-10 Stephen Bryant Liggett Polymorphisms and Haplotypes of the Alpha 2C Adrenergic Receptor Gene
CN104644627A (zh) * 2004-09-14 2015-05-27 科罗拉多大学董事会 基于基因靶向使用布新洛尔的治疗方法
US8602298B2 (en) * 2005-02-07 2013-12-10 Recyclebank, Llc Recycling system and method thereof
US10354474B2 (en) * 2005-02-07 2019-07-16 Recyclebank Llc Incentive-based waste reduction system and method thereof
US10410231B2 (en) * 2005-02-07 2019-09-10 Recyclebank Llc Method of implementing an incentive-based recycling system
US10445756B2 (en) * 2005-02-07 2019-10-15 Recyclebank Llc System and method for managing an incentive-based recycling program
US7949557B2 (en) 2005-02-07 2011-05-24 Recyclebank, Llc Method and system for improving recycling through the use of financial incentives
US20090024479A1 (en) * 2005-02-07 2009-01-22 Recyclebank Llc Community-based recycling system and methods thereof
WO2006089226A1 (en) * 2005-02-17 2006-08-24 University Of Florida Research Foundation, Inc. β-BLOCKER PHARMACOGENETICS IN HEART FAILURE
WO2006122356A1 (en) * 2005-05-16 2006-11-23 Qrscience Pty Ltd A system and method for improving the analysis of chemical substances using nqr
US20100121700A1 (en) * 2006-02-02 2010-05-13 David Wigder System and method for incentive-based resource conservation
US9062347B2 (en) 2007-07-27 2015-06-23 The Regents Of The University Of Colorado, A Body Corporate Endothelin single nucleotide polymorphisms and methods of predicting β-adrenergic receptor targeting agent efficacy
US20090092964A1 (en) * 2007-09-11 2009-04-09 The University Of Cincinnati Methods for Individualizing Cardiovascular Disease Treatment Protocols Based on Beta-1 Adrenergic Receptor Haplotype
US20100185506A1 (en) * 2008-07-18 2010-07-22 Wm Greenops, Llc Systems and methods used in the operation of a recycling enterprise
US8799064B2 (en) * 2009-03-20 2014-08-05 Recyclebank, Llc System for cross-integration of consumer loyalty programs and methods thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US113725A (en) * 1871-04-18 Improvement
US4873191A (en) * 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US5202231A (en) * 1987-04-01 1993-04-13 Drmanac Radoje T Method of sequencing of genomes by hybridization of oligonucleotide probes
IL86724A (en) 1987-06-19 1995-01-24 Siska Diagnostics Inc Methods and kits for amplification and testing of nucleic acid sequences
EP0359789B1 (de) 1988-01-21 1993-08-04 Genentech, Inc. Verstärkung und nachweis von nukleinsäuresequenzen
CA1340807C (en) 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
US5002867A (en) * 1988-04-25 1991-03-26 Macevicz Stephen C Nucleic acid sequence determination by multiple mixed oligonucleotide probes
AU3694689A (en) 1988-04-28 1989-11-24 Mark H. Skolnick Amplified sequence polymorphisms (asps)
US5130238A (en) * 1988-06-24 1992-07-14 Cangene Corporation Enhanced nucleic acid amplification process
ATE138106T1 (de) 1988-07-20 1996-06-15 David Segev Verfahren zur amplifizierung und zum nachweis von nukleinsäuresequenzen
WO1990009455A1 (en) 1989-02-13 1990-08-23 Geneco Pty Ltd Detection of a nucleic acid sequence or a change therein
FR2650840B1 (fr) 1989-08-11 1991-11-29 Bertin & Cie Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications
US5302509A (en) * 1989-08-14 1994-04-12 Beckman Instruments, Inc. Method for sequencing polynucleotides
US6004744A (en) 1991-03-05 1999-12-21 Molecular Tool, Inc. Method for determining nucleotide identity through extension of immobilized primer
US5169766A (en) * 1991-06-14 1992-12-08 Life Technologies, Inc. Amplification of nucleic acid molecules
US6180338B1 (en) 1992-08-04 2001-01-30 Beckman Coulter, Inc. Method, reagent and kit for the detection and amplification of nucleic acid sequences
IL108159A (en) 1993-12-23 1998-02-08 Orgenics Ltd Apparatus for separation, concentration and detection of target molecules in liquid sample
CA2182517C (en) * 1994-02-07 2001-08-21 Theo Nikiforov Ligase/polymerase-mediated primer extension of single nucleotide polymorphisms and its use in genetic analysis
US6498009B1 (en) * 1997-10-10 2002-12-24 University Of Cincinnati β-adrenergic receptor polymorphisms
DE19938390A1 (de) 1999-08-05 2001-03-08 Max Delbrueck Centrum Neue Sequenzvarianten des menschlichen ßl-Adrenozeptorgens und ihre Verwendung
AU2001255448A1 (en) 2000-04-17 2001-10-30 Stephen B. Liggett Alpha-2 adrenergic receptor polymorphisms
US6365618B1 (en) * 2000-12-13 2002-04-02 Conrad M. Swartz Administration of carvedilol to mitigate tardive movement disorders, psychosis, mania, and depression
US20020187491A1 (en) * 2001-02-13 2002-12-12 Johnson Julie A. Beta-adrenoceptor genetic polymorphisms and obesity
AU2002358293A1 (en) * 2001-12-27 2003-07-24 Myriad Genetics, Inc Drug response marker in beta-1 adrenergic receptor gene

Also Published As

Publication number Publication date
EP1670954B1 (de) 2010-11-24
US20050112632A1 (en) 2005-05-26
US7449292B2 (en) 2008-11-11
DE602004030271D1 (de) 2011-01-05
WO2005025409A2 (en) 2005-03-24
EP1670954A4 (de) 2006-11-08
CA2538222A1 (en) 2005-03-24
WO2005025409A3 (en) 2005-12-08
EP1670954A2 (de) 2006-06-21
AU2004272102A1 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
ATE489481T1 (de) Verfahren zur risikobeurteilung, überlebensvorhersage und behandlung von herzversagen und anderen leiden auf der grundlage von polymorphismen adrenerger rezeptoren
Swapna et al. Risk conferred by FokI polymorphism of vitamin D receptor (VDR) gene for essential hypertension
Lannfelt et al. Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders
Schmieder et al. Effect of the angiotensin II type 2-receptor gene (+ 1675 G/A) on left ventricular structure in humans
Sealock et al. Congenic fine-mapping identifies a major causal locus for variation in the native collateral circulation and ischemic injury in brain and lower extremity
Körkkö et al. Sensitivity of conformation sensitive gel electrophoresis in detecting mutations in Marfan syndrome and related conditions
Swan et al. Gain-of-function mutation of the SCN5A gene causes exercise-induced polymorphic ventricular arrhythmias
Baranova et al. Genetic determination of the vascular reactions in humans in response to the diving reflex
Walter et al. 50 years to diagnosis: Autosomal dominant tubular aggregate myopathy caused by a novel STIM1 mutation
Beitelshees et al. CACNA1C gene polymorphisms, cardiovascular disease outcomes, and treatment response
DE60331941D1 (de) Mutationen in nod2 sind bei patienten mit morbus crohn mit fibrostenosebildung assoziiert
Takeda et al. Congenital contractural arachnodactyly complicated with aortic dilatation and dissection: case report and review of literature
ATE529105T1 (de) Zusammensetzung zur rektalen verabreichung kombiniert mit einer oralen zusammentzung enthaltend alpha liponsäure zur behandlung von entzündlicher darmerkrankung
Limosin et al. Association Between Dopamine Receptor D1 Gene Dde I polymorphism and Sensation Seeking in Alcohol‐Dependent Men
Hofer et al. White matter lesion progression: genome-wide search for genetic influences
Altomare et al. The allele (A)-110 in the promoter region of the HSP70-1 gene is unfavorable to longevity in women
Hwang et al. HSD11B1 polymorphisms predicted bone mineral density and fracture risk in postmenopausal women without a clinically apparent hypercortisolemia
Nehring et al. Osteoprotegerin gene rs2073617 and rs3134069 polymorphisms in type 2 diabetes patients and sex-specific rs2073618 polymorphism as a risk factor for diabetic foot
Rojano-Mejía et al. Relation of the estrogen receptor and vitamin D receptor polymorphisms with bone mineral density in postmenopausal Mexican-mestizo women
ATE556324T1 (de) Verwendung von kir-genen zur vorhersage der reaktion auf eine therapie
Yang et al. Association between heat-shock protein 70 gene polymorphisms and DNA damage in peripheral blood lymphocytes among coke-oven workers
Gianotti et al. Mitochondrial DNA copy number is modulated by genetic variation in the signal transducer and activator of transcription 3 (STAT3)
Ferraro et al. Confirmation of multiple seizure susceptibility QTLs on chromosome 15 in C57BL/6J and DBA/2J inbred mice
Guangda et al. Apo e4 allele is associated with endothelium-dependent arterial dilation in women with type 2 diabetes
Kolomeichuk et al. MTNR1A and MTNR1B Gene Variants of the Melatonin Receptor and Arterial Stiffness in Persons without Arterial Hypertension

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties